0.38c

From the Chairmans address.

"Several big pharma companies are now engaged in discussion with Benitec’s senior management.
In vitro, in vivo and clinical data will be the catalysts for advancing these discussions. The cash raised via the cross-over funding in March 2014 and in the recent NASDAQ listing is being used to advance these programs to a standard required by big pharma companies".
​

Science that for what we are told is progressing as expected, we are waiting for results, so is big pharma.
They will report on completion of trial, no material event has occured good or bad (no trial candidate has been cured or deceased) as expected.
Too many other colaborators continuing to use the science so they must see something in it or they would bail!
Time is the factor............................

Can't resist a bargin! I am back in buying.

Hi ho, hi ho, is off to work we go!